Oncocyte VP/Controller/PAO Li Yu resigns effective June 24, 2022

Insight Molecular Diagnostics Inc.

Li Yu resigned as VP, Controller, and Principal Accounting Officer effective June 24, 2022.
Ms. Yu left to pursue other opportunities; no disagreements with the company.
No successor has been named as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Li Yu

Vice President, Controller, and Principal Accounting Officer

IMDX · Insight Molecular Diagnostics Inc.

Effective: 2022-06-24
Filed: June 30, 2022, 7:59 PM ET

Effective June 24, 2022, Li Yu resigned as Vice President, Controller, and Principal Accounting Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Li Yu resigned as Vice President, Controller, and Principal Accounting Officer at Insight Molecular Diagnostics Inc..

Action: resigned
Role: Vice President, Controller, and Principal Accounting Officer

Exact text from the filing

Effective June 24, 2022, Li Yu resigned as Vice President, Controller, and Principal Accounting Officer of the Company.

View on SEC.gov

Insight Molecular Diagnostics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-018233

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.